Truist lowered the firm’s price target on Comerica to $55 from $60 but keeps a Buy rating on the shares. The firm is citing the management’s intra-quarter update indicating lower net interest income and higher expenses along with slower loan growth this year, the analyst tells investors in a research note. Truist adds however that it remains positive on the stock as Comerica’s potential earnings inflection in Q4 and in 2025 “remains attractive”.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMA:
